These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 31104729

  • 1. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
    Love-Koh J, Cookson R, Gutacker N, Patton T, Griffin S.
    Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
    [Abstract] [Full Text] [Related]

  • 2. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
    Meunier A, Longworth L, Gomes M, Ramagopalan S, Garrison LP, Popat S.
    Pharmacoeconomics; 2023 Aug; 41(8):1011-1025. PubMed ID: 37296369
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Intervention Impact on Health Inequality for Resource Allocation.
    Griffin S, Love-Koh J, Pennington B, Owen L.
    Med Decis Making; 2019 Apr; 39(3):171-182. PubMed ID: 30819034
    [Abstract] [Full Text] [Related]

  • 4. Equity and economic evaluation of system-level health interventions: A case study of Brazil's Family Health Program.
    Love-Koh J, Mirelman A, Suhrcke M.
    Health Policy Plan; 2021 Apr 21; 36(3):229-238. PubMed ID: 33386400
    [Abstract] [Full Text] [Related]

  • 5. Distributional impact of the Malawian Essential Health Package.
    Arnold M, Nkhoma D, Griffin S.
    Health Policy Plan; 2020 Jul 01; 35(6):646-656. PubMed ID: 32361730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Distributional Cost-Effectiveness Analysis: A Tutorial.
    Asaria M, Griffin S, Cookson R.
    Med Decis Making; 2016 Jan 01; 36(1):8-19. PubMed ID: 25908564
    [Abstract] [Full Text] [Related]

  • 8. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S, Williams I, McIver S.
    Health Econ; 2007 Feb 01; 16(2):179-93. PubMed ID: 16960851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How health inequalities accumulate and combine to affect treatment value: A distributional cost-effectiveness analysis of smoking cessation interventions.
    Love-Koh J, Pennington B, Owen L, Taylor M, Griffin S.
    Soc Sci Med; 2020 Nov 01; 265():113339. PubMed ID: 33039733
    [Abstract] [Full Text] [Related]

  • 11. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal.
    Morton A, Adler AI, Bell D, Briggs A, Brouwer W, Claxton K, Craig N, Fischer A, McGregor P, van Baal P.
    Health Econ; 2016 Aug 01; 25(8):933-8. PubMed ID: 27374115
    [Abstract] [Full Text] [Related]

  • 12. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
    Jansen JP, Ragavan MV, Chen C, Douglas MP, Phillips KA.
    Value Health; 2023 Dec 01; 26(12):1697-1710. PubMed ID: 37741446
    [Abstract] [Full Text] [Related]

  • 13. Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis.
    Yang F, Angus C, Duarte A, Gillespie D, Walker S, Griffin S.
    Med Decis Making; 2020 Jul 01; 40(5):606-618. PubMed ID: 32608317
    [Abstract] [Full Text] [Related]

  • 14.
    Desser AS, Arentz-Hansen H, Fagerlund BF, Harboe I, Lauvrak V.
    ; 2017 08 25. PubMed ID: 29553663
    [Abstract] [Full Text] [Related]

  • 15. Estimating 'costs' for cost-effectiveness analysis.
    Miners A.
    Pharmacoeconomics; 2008 08 25; 26(9):745-51. PubMed ID: 18767895
    [Abstract] [Full Text] [Related]

  • 16. Distributional impact of infectious disease interventions in the Ethiopian Essential Health Service Package: a modelling study.
    Assebe LF, Norheim O.
    BMJ Open; 2023 Jul 17; 13(7):e067658. PubMed ID: 37460265
    [Abstract] [Full Text] [Related]

  • 17. Distributional cost effectiveness analysis of West Yorkshire low emission zone policies.
    Griffin S, Walker S, Sculpher M.
    Health Econ; 2020 May 17; 29(5):567-579. PubMed ID: 32003147
    [Abstract] [Full Text] [Related]

  • 18. Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis.
    Collins B, Kypridemos C, Cookson R, Parvulescu P, McHale P, Guzman-Castillo M, Bandosz P, Bromley H, Capewell S, O'Flaherty M.
    Prev Med; 2020 Jan 17; 130():105879. PubMed ID: 31678586
    [Abstract] [Full Text] [Related]

  • 19. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S, Sussex J, Hughes D, Devlin N.
    BMC Health Serv Res; 2016 Mar 25; 16():103. PubMed ID: 27012523
    [Abstract] [Full Text] [Related]

  • 20. Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme.
    Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P.
    Health Econ; 2015 Jun 25; 24(6):742-54. PubMed ID: 24798212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.